Minton, Susan

Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells

Gritsko, T., Williams, A., Turkson, J., Kaneko, S., Bowman, T., Huang, M., Nam, S., Eweis, I., Diaz, N., Sullivan, D., et al. (2006) · Clinical Cancer Research

Cytokine Signaling Pathways and InteractionsCell death mechanisms and regulation

Cited by 563

A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer

Munster, P. N., Thurn, K. T., Thomas, S., Raha, P., Lacevic, M., Miller, A., Melisko, M., Ismail-Khan, R., Rugo, H., Moasser, M., et al. (2011) · British Journal of Cancer

Histone Deacetylase Inhibitors ResearchAdvanced Breast Cancer Therapies

Cited by 391

A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors

Soliman, H. H., Jackson, E., Neuger, T., Dees, E. C., Harvey, R. D., Han, H., Ismail-Khan, R., Minton, S., Vahanian, N. N., Link, C., et al. (2014) · Oncotarget

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 174

History of Major Depressive Disorder Prospectively Predicts Worse Quality of Life in Women with Breast Cancer

Jim, H. S. L., Small, B. J., Minton, S., Andrykowski, M., & Jacobsen, P. B. (2012) · Annals of Behavioral Medicine

Cancer survivorship and careCancer-related cognitive impairment studies

Cited by 32

Necdin, a negative growth regulator, is a novel STAT3 target gene down-regulated in human cancer

Haviland, R., Eschrich, S., Bloom, G., Ma, Y., Minton, S., Jove, R., & Cress, W. D. (2011) · PLoS ONE

Cytokine Signaling Pathways and InteractionsProtein Tyrosine Phosphatases

Cited by 19